Gibson Dunn & Crutcher LLP Advised KKR & Co. Inc. on its Acquisition of Clinisupplies from Healthium

December 9, 2022

Gibson Dunn & Crutcher LLP advised New York-based investment company KKR & Co. Inc. (KKR) on its acquisition of Clinisupplies from Healthium.

KKR acquired Clinisupplies through KKR Health Care Strategic Growth Fund II, a $4 billion fund focused on investing in high-growth healthcare companies. Financial details of the transaction were not disclosed.

Co-Head of Private Equity Wim De Vlieger and Corporate Partner Nick Tomlinson co-led the team advising KKR, with support from associates Jakob Egle, Emily Mattley, Sarah Reder and Paavni Anand.

The Gibson Dunn team also included advice provided by Technology Transactions Partners Alison Beal and Joel Harrison, Employment Partner James Cox, Real Estate Co-Chair Alan Samson, Tax Co-Chair Sandy Bhogal, Dispute Resolution Partner Patrick Doris, Antitrust and Competition Partners Ali Nikpay and Attila Borsos, and Global Finance Partner Ben Myers.

The team also included associates Chris Puttock and Libby Pica, Heather Gibbons, Freya Hocking, Bridget English and James Chandler, Irene Polieri, Charlie Osborne, Ben Nunez and Chloe A. Kannangara.

The Firm also advised KKR, amongst other matters, on its minority investment in Norwegian telecommunications company Telenor in October and on its Series C investment in Privy, a leading digital trust provider in Indonesia, in November.